Riverhead Capital Management’s Integra LifeSciences IART Stock Holding History

Riverhead Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$290K	Hold	4,826	–	–	0.01%	955
2019 Q2	$270K	Hold	4,826	–	–	0.01%	1013
2019 Q1	$269K	Hold	4,826	–	–	0.01%	990
2018 Q4	$218K	Buy	4,826 +200	+4%	+$11K	0.01%	1030
2018 Q3	$305K	Buy	4,626 +1,200	+35%	+$74.6K	0.01%	997
2018 Q2	$221K	Hold	3,426	–	–	0.01%	1043
2018 Q1	$190K	Hold	3,426	–	–	0.01%	1092
2017 Q4	$164K	Buy	3,426 +600	+21%	+$29.4K	0.01%	1162
2017 Q3	$143K	Buy	2,826 +427	+18%	+$21.9K	0.01%	1138
2017 Q2	$131K	Buy	2,399 +799	+50%	+$38.2K	0.01%	1111
2017 Q1	$67K	Buy	1,600 +200	+14%	+$8.55K	﹤0.01%	1164
2016 Q4	$60K	Hold	1,400	–	–	﹤0.01%	1181
2016 Q3	$58K	Sell	1,400 -1,592	-53%	-$66.7K	﹤0.01%	1132
2016 Q2	$69K	Sell	2,992 -8,908	-75%	-$320K	﹤0.01%	1265
2016 Q1	$401K	Sell	11,900 -1,700	-13%	-$53K	0.01%	969
2015 Q4	$461K	Buy	13,600 +10,000	+278%	+$313K	0.01%	936
2015 Q3	$107K	Buy	+3,600	New	+$113K	﹤0.01%	1058

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Riverhead Capital Management's IART Position: Q3 2019 in Review

Riverhead Capital Management held its Integra LifeSciences (IART) position steady in Q3 2019 at 4,826 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #955.

Riverhead Capital Management first reported a position in IART in Q3 2015 and has held it in 17 quarters since. The position peaked at $461K in Q4 2015. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Riverhead Capital Management held 4,826 shares of Integra LifeSciences worth $290K as of Q3 2019.
Riverhead Capital Management left its Integra LifeSciences share count unchanged in Q3 2019.
Integra LifeSciences made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #955 holding.
Riverhead Capital Management first reported a position in Integra LifeSciences in Q3 2015 and has held it in 17 quarters since.
Riverhead Capital Management's Integra LifeSciences position peaked at $461K in Q4 2015.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.